(Q80203589)
Statements
Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study (English)
Thuluvath PJ
Maheshwari A
Wong F
Yoo HW
Parikh C
Steare S
1 September 2006